Novavax Inc (NASDAQ:NVAX)

6.07
Delayed Data
As of Mar 24
 +0.31 / +5.38%
Today’s Change
5.61
Today|||52-Week Range
82.41
-40.95%
Year-to-Date
Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know
Mar 23 / Zacks.com - Paid Partner Content
2 Growth Stocks That Are Trading at a Huge Discount Right Now -- Maybe Rightfully So
Mar 16 / MotleyFool.com - Paid Partner Content
Why Novavax Stock Slipped on Thursday
Mar 23 / MotleyFool.com - Paid Partner Content
This Growth Stock Is Down 90%. Is It Time to Sell or Buy?
Mar 12 / MotleyFool.com - Paid Partner Content
1 Green Flag and 1 Red Flag for Novavax
Mar 18 / MotleyFool.com - Paid Partner Content
Covid vaccine maker Novavax says it may not survive
Mar 01 / CNN.com
Novavax (NVAX) Gains But Lags Market: What You Should Know
Mar 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close5.76
Today’s open5.72
Day’s range5.71 - 6.13
Volume188,132
Average volume (3 months)6,833,776
Market cap$514.5M
Data as of 4:00pm ET, 03/24/2023

Growth & Valuation

Earnings growth (last year)+64.09%
Earnings growth (this year)+34.50%
Earnings growth (next 5 years)-69.66%
Revenue growth (last year)+39.49%
P/E ratioNM
Price/Sales0.50
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALECAlector Inc+0.26+4.38%
AGENAgenus Inc+0.02+1.01%
EDITEditas Medicine Inc+0.05+0.74%
----
Data as of 3:59pm ET, 03/24/2023

Financials

Next reporting dateMay 8, 2023
EPS forecast (this quarter)-$3.08
Annual revenue (last year)$1.6B
Annual profit (last year)-$657.9M
Net profit margin-41.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts